Thanks for posting that article. We can be hopeful the Generex vaccine will be enough of an improvement over what is currently available that it will be given consideration. Obviously not good news. Not sure what the FDA considers in discussions. Maybe we are far enough along, maybe not. We are certainly not in discussions for an authorization so if that is the criteria than we are on the outside looking in unless our vaccine proves itself in trials to be superior.

This is why we needed a big pharma partner here in the US. Lack of funding is slowing thing down too much.